Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Mauro Agnifili , Nedy Brambilla , Luca Testa , et al Added: 3 years ago
Introduction The Istituto Clinico Sant’Ambrogio started its Trans Aortic Valve Implantation (TAVI) programme in 2008 and has since performed more than 450 cases. The percutaneous femoral approach is the preferred access as it is the least invasive and often requires only mild or local sedation. Nevertheless, our institution has performed several cases by the subclavian and transaortic routes… View more
Author(s): Michael Lauterbach , Bruno Sontag , Karl-Eugen Hauptmann Added: 3 years ago
Over the past nine years, since the first transcatheter aortic valve implantation (TAVI) by Cribier et al.1 in France in 2002, this new technique has enthralled cardiologists all over the world. With the deployment of TAVI – about 40,000 procedures have been carried out worldwide so far – cardiologists intruded into the previously unshared domain of surgical aortic valve replacement. Albeit… View more
Author(s): Dr Won-Keun Kim Start date: Oct 23, 2018
Transcatheter aortic valve implantation (TAVI) has emerged to be a viable treatment option for patients suffering from Severe Aortic Stenosis. The transfemoral approach is the most common access route for TAVI and associated with most favourable clinical outcomes. However, with a population with increasingly complex vasculature, the incidence of vascular complications in TAVI remains high… View more
Author(s): Holger Eggebrecht , Philipp Kahlert , Polykarpos Patsalis , et al Added: 3 years ago
Transcatheter aortic valve implantation (TAVI) has recently emerged as a novel, minimally invasive treatment option for patients with symptomatic severe aortic valve stenosis deemed at high risk of conventional surgery due to excessive co-morbidities.1,2 Clinical results of TAVI are encouraging and the number of patients treated with this new method continues to grow exponentially in an… View more
Author(s): John Jose , Gert Richardt , Mohamed Abdel-Wahab Added: 3 years ago
Transcatheter aortic valve implantation (TAVI) has undergone tremendous technological advancements since the first successful implantation in 2002 for symptomatic severe aortic valve stenosis (AS).1 It is currently considered as the standard of care for severe AS patients who have high surgical risk or may be deemed unsuitable for surgery.2 Broadly, there are two main categories of transcatheter… View more
Author(s): Stephane Noble , Marco Roffi Added: 3 years ago
Since the first human transcatheter aortic valve implantation (TAVI)performed through an antegrade transfemoral approach (i.e. femoral venous access, transseptal puncture advancement of the device to the left ventricle and antegradely through the aortic valve), the venous approach has been abandoned and different arterial access routes such as the transfemoral, transapical, subclavian or direct… View more
Author(s): Grégory Ducrocq , Dominique Himbert , Eric Brochet , et al Added: 3 years ago
Aortic stenosis (AS) is currently the most frequent native valve disease in Europe and is most often seen in elderly patients with co-morbidities.1 Valve replacement is the definitive therapy for patients with severe AS who have symptoms or objective consequences such as left ventricular (LV) dysfunction.2,3 However, the risk of surgery may be higher in elderly patients with significant co… View more
Author(s): Jacques Théron , Leopoldo Guimaraens , Alfredo Casasco , et al Added: 3 years ago
The use of cerebral protection during carotid stenting is being less and less contested. The protection systems currently available present a certain number of inconveniences. The new system that the authors propose is an evolution of the cerebral protection concept by temporary occlusion of the distal internal carotid.1-3 Experience with several hundred endovascular treatments of the carotid… View more